Product Code: TMRGL45447
Medical Foods Market - Scope of Report:
TMR's report on the global medical foods market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global medical foods market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical foods market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical foods market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical foods market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical foods market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical foods market.
The report delves into the competitive landscape of the global medical foods market. Key players operating in the global medical foods market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical foods market profiled in this report.
Key Questions Answered in Global Medical Foods Market Report:
- What is the sales/revenue generated by medical foods across all regions during the forecast period?
- What are the opportunities in the global medical foods market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Medical Foods Market - Research Objectives and Research Approach:
The comprehensive report on the global medical foods market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global medical foods market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical foods market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Foods Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
5. Key Insights
- 5.1. Important market developments
- 5.2. Top 3 Players Operating in the Market Space
- 5.3. New competitive market entrants
- 5.4. Medical food regulation overview
- 5.5. Reimbursement Scenario
- 5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples
6. Global Medical Foods Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017-2031
- 6.3.1. Pills
- 6.3.2. Powder
- 6.3.3. Liquid
- 6.3.4. Others
- 6.4. Market Attractiveness Analysis, by Product Type
7. Global Medical Foods Market Analysis and Forecast, by Disease Type
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Disease Type, 2017-2031
- 7.3.1. Orphan Disease
- 7.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 7.3.1.2. Sickle Cell Anemia
- 7.3.1.3. Hemophilia
- 7.3.1.4. Others
- 7.3.2. Cancer
- 7.3.3. Neurological & Psychological Disorders
- 7.3.4. Metabolic Disorders
- 7.3.5. Pain Management
- 7.3.6. Gastrointestinal Disorders
- 7.3.7. Ophthalmology
- 7.3.8. Diabetes
- 7.3.9. Phenylketonuria (PKU)
- 7.3.10. Epilepsy
- 7.4. Market Attractiveness Analysis, by Disease Type
8. Global Medical Foods Market Analysis and Forecast, by Route of Administration
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Route of Administration, 2017-2031
- 8.3.1. Oral
- 8.3.2. Enteral
- 8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 9.3.1. Pharmacies & Drug Stores
- 9.3.2. Online Channels
- 9.3.3. Supermarkets & Hypermarkets
- 9.3.4. Others
- 9.4. Market Attractiveness Analysis, by Distribution Channel
10. Global Medical Foods Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness Analysis, by Region
11. North America Medical Foods Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product Type, 2017-2031
- 11.2.1. Pills
- 11.2.2. Powder
- 11.2.3. Liquid
- 11.2.4. Others
- 11.3. Market Value Forecast, by Disease Type, 2017-2031
- 11.3.1. Orphan Disease
- 11.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 11.3.1.2. Sickle Cell Anemia
- 11.3.1.3. Hemophilia
- 11.3.1.4. Others
- 11.3.2. Cancer
- 11.3.3. Neurological & Psychological Disorders
- 11.3.4. Metabolic Disorders
- 11.3.5. Pain Management
- 11.3.6. Gastrointestinal Disorders
- 11.3.7. Ophthalmology
- 11.3.8. Diabetes
- 11.3.9. Phenylketonuria (PKU)
- 11.3.10. Epilepsy
- 11.4. Market Value Forecast, by Route of Administration, 2017-2031
- 11.4.1. Oral
- 11.4.2. Enteral
- 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.5.1. Pharmacies & Drug Stores
- 11.5.2. Online Channels
- 11.5.3. Supermarkets & Hypermarkets
- 11.5.4. Others
- 11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Disease Type
- 11.7.3. By Route of Administration
- 11.7.4. By Distribution Channel
- 11.7.5. By Country
12. Europe Medical Foods Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product Type, 2017-2031
- 12.2.1. Pills
- 12.2.2. Powder
- 12.2.3. Liquid
- 12.2.4. Others
- 12.3. Market Value Forecast, by Disease Type, 2017-2031
- 12.3.1. Orphan Disease
- 12.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 12.3.1.2. Sickle Cell Anemia
- 12.3.1.3. Hemophilia
- 12.3.1.4. Others
- 12.3.2. Cancer
- 12.3.3. Neurological & Psychological Disorders
- 12.3.4. Metabolic Disorders
- 12.3.5. Pain Management
- 12.3.6. Gastrointestinal Disorders
- 12.3.7. Ophthalmology
- 12.3.8. Diabetes
- 12.3.9. Phenylketonuria (PKU)
- 12.3.10. Epilepsy
- 12.4. Market Value Forecast, by Route of Administration, 2017-2031
- 12.4.1. Oral
- 12.4.2. Enteral
- 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.5.1. Pharmacies & Drug Stores
- 12.5.2. Online Channels
- 12.5.3. Supermarkets & Hypermarkets
- 12.5.4. Others
- 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. by Product Type
- 12.7.2. By Disease Type
- 12.7.3. By Route of Administration
- 12.7.4. By Distribution Channel
- 12.7.5. By Country/Sub-region
13. Asia Pacific Medical Foods Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product Type, 2017-2031
- 13.2.1. Pills
- 13.2.2. Powder
- 13.2.3. Liquid
- 13.2.4. Others
- 13.3. Market Value Forecast, by Disease Type, 2017-2031
- 13.3.1. Orphan Disease
- 13.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 13.3.1.2. Sickle Cell Anemia
- 13.3.1.3. Hemophilia
- 13.3.1.4. Others
- 13.3.2. Cancer
- 13.3.3. Neurological & Psychological Disorders
- 13.3.4. Metabolic Disorders
- 13.3.5. Pain Management
- 13.3.6. Gastrointestinal Disorders
- 13.3.7. Ophthalmology
- 13.3.8. Diabetes
- 13.3.9. Phenylketonuria (PKU)
- 13.3.10. Epilepsy
- 13.4. Market Value Forecast, by Route of Administration, 2017-2031
- 13.4.1. Oral
- 13.4.2. Enteral
- 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.5.1. Pharmacies & Drug Stores
- 13.5.2. Online Channels
- 13.5.3. Supermarkets & Hypermarkets
- 13.5.4. Others
- 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. by Product Type
- 13.7.2. By Disease Type
- 13.7.3. By Route of Administration
- 13.7.4. By Distribution Channel
- 13.7.5. By Country/Sub-region
14. Latin America Medical Foods Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product Type, 2017-2031
- 14.2.1. Pills
- 14.2.2. Powder
- 14.2.3. Liquid
- 14.2.4. Others
- 14.3. Market Value Forecast, by Disease Type, 2017-2031
- 14.3.1. Orphan Disease
- 14.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 14.3.1.2. Sickle Cell Anemia
- 14.3.1.3. Hemophilia
- 14.3.1.4. Others
- 14.3.2. Cancer
- 14.3.3. Neurological & Psychological Disorders
- 14.3.4. Metabolic Disorders
- 14.3.5. Pain Management
- 14.3.6. Gastrointestinal Disorders
- 14.3.7. Ophthalmology
- 14.3.8. Diabetes
- 14.3.9. Phenylketonuria (PKU)
- 14.3.10. Epilepsy
- 14.4. Market Value Forecast, by Route of Administration, 2017-2031
- 14.4.1. Oral
- 14.4.2. Enteral
- 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.5.1. Pharmacies & Drug Stores
- 14.5.2. Online Channels
- 14.5.3. Supermarkets & Hypermarkets
- 14.5.4. Others
- 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
- 14.7. Market Attractiveness Analysis
- 14.7.1. by Product Type
- 14.7.2. By Disease Type
- 14.7.3. By Route of Administration
- 14.7.4. By Distribution Channel
- 14.7.5. By Country/Sub-region
15. Middle East & Africa Medical Foods Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product Type, 2017-2031
- 15.2.1. Pills
- 15.2.2. Powder
- 15.2.3. Liquid
- 15.2.4. Others
- 15.3. Market Value Forecast, by Disease Type, 2017-2031
- 15.3.1. Orphan Disease
- 15.3.1.1. Duchenne Muscular Dystrophy (DMD)
- 15.3.1.2. Sickle Cell Anemia
- 15.3.1.3. Hemophilia
- 15.3.1.4. Others
- 15.3.2. Cancer
- 15.3.3. Neurological & Psychological Disorders
- 15.3.4. Metabolic Disorders
- 15.3.5. Pain Management
- 15.3.6. Gastrointestinal Disorders
- 15.3.7. Ophthalmology
- 15.3.8. Diabetes
- 15.3.9. Phenylketonuria (PKU)
- 15.3.10. Epilepsy
- 15.4. Market Value Forecast, by Route of Administration, 2017-2031
- 15.4.1. Oral
- 15.4.2. Enteral
- 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
- 15.5.1. Pharmacies & Drug Stores
- 15.5.2. Online Channels
- 15.5.3. Supermarkets & Hypermarkets
- 15.5.4. Others
- 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
- 15.7. Market Attractiveness Analysis
- 15.7.1. by Product Type
- 15.7.2. By Disease Type
- 15.7.3. By Route of Administration
- 15.7.4. By Distribution Channel
- 15.7.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (by tier and size of companies)
- 16.2. Competitive Business Strategies
- 16.3. Company Profiles
- 16.3.1. Nutricia (Danone)
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. Nestle S.A.
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. Abbott Laboratories
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. Mead Johnson Nutrition
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Fresenius Kabi
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Friso
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. Morinaga Milk Industry
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
- 16.3.8. Primus Pharmaceuticals, Inc.
- 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.8.2. Product Portfolio
- 16.3.8.3. Financial Overview
- 16.3.8.4. SWOT Analysis
- 16.3.8.5. Strategic Overview
- 16.3.9. Targeted Medical Pharma, Inc.
- 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.9.2. Product Portfolio
- 16.3.9.3. Financial Overview
- 16.3.9.4. SWOT Analysis
- 16.3.9.5. Strategic Overview
- 16.3.10. Medtrition, Inc.
- 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.10.2. Product Portfolio
- 16.3.10.3. Financial Overview
- 16.3.10.4. SWOT Analysis
- 16.3.10.5. Strategic Overview